Kamala Bhavaraju, Ph.D.

Affiliations: 
2010 Molecular and Cellular Physiology Temple University, Philadelphia, PA, United States 
Area:
Physiology Biology
Google:
"Kamala Bhavaraju"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Satya P. Kunapuli grad student 2010 Temple University
 (Molecular physiology of thromboxane A2 generation.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bynagari-Settipalli YS, Lakhani P, Jin J, et al. (2012) Protein kinase C isoform ε negatively regulates ADP-induced calcium mobilization and thromboxane generation in platelets. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 1211-9
Bhavaraju K, Lakhani PR, Dorsam RT, et al. (2011) G(12/13) signaling pathways substitute for integrin αIIbβ3-signaling for thromboxane generation in platelets. Plos One. 6: e16586
Bhavaraju K, Georgakis A, Jin J, et al. (2010) Antagonism of P2Y₁₂ reduces physiological thromboxane levels. Platelets. 21: 604-9
Bhavaraju K, Mayanglambam A, Rao AK, et al. (2010) P2Y(12) antagonists as antiplatelet agents - Recent developments. Current Opinion in Drug Discovery & Development. 13: 497-506
Garcia A, Kim S, Bhavaraju K, et al. (2010) Role of phosphoinositide 3-kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways. The Biochemical Journal. 429: 369-77
Bynagari YS, Nagy B, Tuluc F, et al. (2009) Mechanism of activation and functional role of protein kinase Ceta in human platelets. The Journal of Biological Chemistry. 284: 13413-21
Chari R, Getz T, Nagy B, et al. (2009) Protein kinase C[delta] differentially regulates platelet functional responses. Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 699-705
Nagy B, Bhavaraju K, Getz T, et al. (2009) Impaired activation of platelets lacking protein kinase C-theta isoform. Blood. 113: 2557-67
Bhavaraju K, Kim S, Daniel JL, et al. (2008) Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2, 3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in platelets. European Journal of Pharmacology. 580: 285-90
See more...